Tag AMZN
Patient Capital Management's Opportunity Equity Strategy surpassed the market to end up 26.5%, 150bps ahead of the S&P 500âs 25.0%. Click here to read the full fund letter...
Continue Reading
Read here for highlights on Marvell Technology's AI revenue targets and growth prospects, which make it an attractive investment opportunity for investors...
Continue ReadingMarvell Technology is seeing strong AI growth, despite potential challenges. Find out why MRVL stock offers potential upside and a good buy on dips...
Continue ReadingThe Heartland Value Fund outperformed its benchmark for Q4 2024 and also the past 1, 3 and 5 years. Click here to read the full commentary...
Continue Reading
We closed the year with a respectable overall performance, even as the market cooled in December. Read more here...
Continue ReadingOur Fund is the second-best performer since its inception in November 2010 in the Investment Association Global sector of 162 funds. Read more here...
Continue ReadingApple's decision to sidestep the AI arms race is a winning move. See why I think AAPL stock may be the safest investment among the magnificent seven...
Continue ReadingRecently, one of the most dynamic high-yield, high-growth segments of the market has been dealt severe headwinds. I share how I am navigating these choppy waters...
Continue ReadingFinancial writer discusses the impact of interest rates on S&P 500 and REITs, Baby Boomers' economic influence, and dividend growth stock choices...
Continue ReadingRead here for an analysis of Invesco S&P 500 Top 50 ETF (XLG) for long-term capital growth, which outperforms the S&P 500 Index with top US stocks...
Continue Reading